BACK TO INDEX

Publications of A. M. Bonnet
Articles in journal or book chapters
  1. H. El Otmani, N. Jodoin, S. Yaici, M. L. Welter, A. M. Bonnet, S. Navarro, B. Pidoux, D. Dormont, P. Cornu, and Y. Agid. [Can subthalamic nucleus stimulation reveal parkinsonian rest tremor?]. Rev Neurol (Paris), 165(1):81-5, 2009. Note: English AbstractJournal ArticleFrance. [WWW] Keyword(s): Adrenal Rest Tumor/*diagnosis, Antiparkinson Agents/therapeutic use, *Deep Brain Stimulation, Female, Humans, Levodopa/therapeutic use, Male, Middle Aged, Muscle Rigidity/etiology, Neurosurgical Procedures, Parkinson Disease/*diagnosis, Subthalamic Nucleus/*physiology, Tremor/etiology.


  2. P. Ibanez, S. Lesage, S. Janin, E. Lohmann, F. Durif, A. Destee, A. M. Bonnet, C. Brefel-Courbon, S. Heath, D. Zelenika, Y. Agid, A. Durr, and A. Brice. Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. Arch Neurol, 66(1):102-8, 2009. Note: French Parkinson's Disease Genetics Study GroupJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Brain Chemistry/*genetics, Chromosome Breakage, DNA Mutational Analysis, DNA Repeat Expansion/genetics, Female, Gene Dosage/genetics, Genes, Dominant/*genetics, Genetic Predisposition to Disease/*genetics, Genetic Screening, Genotype, Haplotypes/genetics, Humans, Male, Microsatellite Repeats/genetics, Middle Aged, Oligonucleotide Array Sequence Analysis, Parkinsonian Disorders/*genetics/*metabolism/physiopathology, Polymorphism, Single Nucleotide/genetics, alpha-Synuclein/*genetics.


  3. R. Beato, R. Levy, B. Pillon, C. Vidal, S. T. du Montcel, B. Deweer, A. M. Bonnet, J. L. Houeto, B. Dubois, and F. Cardoso. Working memory in Parkinson's disease patients: clinical features and response to levodopa. Arq Neuropsiquiatr, 66(2a):147-151, 2008. Note: Journal article. [WWW]


  4. F. Bonneville, F. Bloch, E. Kurys, S. T. du Montcel, M. L. Welter, A. M. Bonnet, Y. Agid, D. Dormont, and J. L. Houeto. Camptocormia and Parkinson's disease: MR imaging. Eur Radiol, 18(8):1710-9, 2008. Note: Journal ArticleGermany. [WWW]


  5. S. Greffard, M. Verny, A. M. Bonnet, D. Seilhean, J. J. Hauw, and C. Duyckaerts. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging, 2008. Note: Journal article. [WWW]


  6. P. Charles, A. Camuzat, N. Benammar, F. Sellal, A. Destee, A. M. Bonnet, S. Lesage, I. Le Ber, G. Stevanin, A. Durr, and A. Brice. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?. Neurology, 2007. Note: French Parkinson's Disease Genetics Study Group*Journal article. [WWW]


  7. S. Lesage, S. Janin, E. Lohmann, A. L. Leutenegger, L. Leclere, F. Viallet, P. Pollak, F. Durif, S. Thobois, V. Layet, M. Vidailhet, Y. Agid, A. Durr, A. Brice, A. M. Bonnet, M. Borg, E. Broussolle, P. Damier, A. Destee, M. Martinez, C. Penet, O. Rasco, F. Tison, C. Tranchan, and M. Verin. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans. Arch Neurol, 64(3):425-30, 2007. Note: French Parkinson's Disease Genetics Study GroupNs41723-01a1/ns/nindsComparative StudyJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, DNA Mutational Analysis/methods, Europe, Exons/*genetics, Female, Histidine/genetics, Humans, Male, Middle Aged, *Mutation, Parkinson Disease/*genetics, Protein-Serine-Threonine Kinases/*genetics, Serine/genetics, Threonine/genetics, Tyrosine/genetics.


  8. W. M. Schupbach, D. Maltete, J. L. Houeto, S. T. du Montcel, L. Mallet, M. L. Welter, M. Gargiulo, C. Behar, A. M. Bonnet, V. Czernecki, B. Pidoux, S. Navarro, D. Dormont, P. Cornu, and Y. Agid. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology, 68(4):267-71, 2007. Note: Comparative StudyJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Activities of Daily Living/psychology, Adult, Antiparkinson Agents/therapeutic use, Deep Brain Stimulation, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neurosurgical Procedures/*methods, Parkinson Disease/epidemiology/psychology/*therapy, Prospective Studies, Quality of Life/psychology, Subthalamic Nucleus/physiology, Time Factors.


  9. M. W. Schupbach, M. L. Welter, A. M. Bonnet, A. Elbaz, B. R. Grossardt, V. Mesnage, J. L. Houeto, D. Maltete, L. Mallet, W. A. Rocca, A. Mallet, and Y. Agid. Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus. Mov Disord, 22(2):257-61, 2007. Note: R01 ns33978/ns/nindsJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the Movement Disorder Society. [WWW] Keyword(s): Adult, Aged, Cause of Death, Cognition Disorders/diagnosis, Deep Brain Stimulation/*methods, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neuropsychological Tests, Parkinson Disease/epidemiology/*mortality/*therapy, Postoperative Period, Predictive Value of Tests, Subthalamic Nucleus/*physiology, Survival Rate.


  10. F. Bloch, J. L. Houeto, S. Tezenas du Montcel, F. Bonneville, F. Etchepare, M. L. Welter, S. Rivaud-Pechoux, V. Hahn-Barma, T. Maisonobe, C. Behar, J. Y. Lazennec, E. Kurys, I. Arnulf, A. M. Bonnet, and Y. Agid. Parkinson's disease with camptocormia. J Neurol Neurosurg Psychiatry, 77(11):1223-8, 2006. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Aged, Basal Ganglia/physiopathology, Dystonia/*etiology/physiopathology, Electromyography, Electrophysiology, Female, Humans, Male, Middle Aged, Muscle, Skeletal/pathology, Parkinson Disease/*complications/*physiopathology, *Posture, Prospective Studies, Walking.


  11. S. Greffard, M. Verny, A. M. Bonnet, J. Y. Beinis, C. Gallinari, S. Meaume, F. Piette, J. J. Hauw, and C. Duyckaerts. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol, 63(4):584-8, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Aged, Aged, 80 and over, Cell Count, Female, Humans, Lewy Bodies/metabolism/*pathology, Lewy Body Disease/diagnosis/pathology/physiopathology, Longitudinal Studies, Male, Movement/physiology, Nerve Degeneration/metabolism/*pathology/physiopathology, Neurologic Examination, Neurons/metabolism/*pathology, Parkinsonian Disorders/*diagnosis/pathology/*physiopathology, Predictive Value of Tests, Prospective Studies, Statistics, Substantia Nigra/*pathology/physiopathology.


  12. W. M. Schupbach, D. Maltete, J. L. Houeto, S. Tezenas du Montcel, L. Mallet, M. L. Welter, M. Gargiulo, C. Behar, A. M. Bonnet, V. Czernecki, B. Pidoux, S. Navarro, D. Dormont, P. Cornu, and Y. Agid. Neurosurgery at an earlier stage of Parkinson disease. A randomized, controlled trial. Neurology, 2006. Note: Journal article. [WWW]


  13. M. W. Schupbach, M. L. Welter, A. M. Bonnet, A. Elbaz, B. R. Grossardt, V. Mesnage, J. L. Houeto, D. Maltete, L. Mallet, W. A. Rocca, A. Mallet, and Y. Agid. Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus. Mov Disord, 2006. Note: Journal article. [WWW]


  14. F. Bonneville, M. L. Welter, C. Elie, S. T. du Montcel, D. Hasboun, C. Menuel, J. L. Houeto, A. M. Bonnet, V. Mesnage, B. Pidoux, S. Navarro, P. Cornu, Y. Agid, and D. Dormont. Parkinson disease, brain volumes, and subthalamic nucleus stimulation. Neurology, 64(9):1598-604, 2005. Note: Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Activities of Daily Living, Age of Onset, Aged, Antiparkinson Agents/administration & dosage, Atrophy/etiology/*pathology/physiopathology, Brain/*pathology/physiopathology, Brain Mapping/methods, Deep Brain Stimulation/methods/*standards, Female, Humans, Magnetic Resonance Imaging/*methods, Male, Middle Aged, Parkinson Disease/*pathology/physiopathology/*therapy, Patient Selection, Predictive Value of Tests, Prognosis, Retrospective Studies, Statistics, Subthalamic Nucleus/*physiology, Treatment Outcome.


  15. J. C. Corvol, M. Schupbach, and A. M. Bonnet. [Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations]. Rev Neurol (Paris), 161(6-7):637-43, 2005. Note: Centre d'Investigation Clinique et Federation des Maladies du Systeme Nerveux, Hopital de la Pitie-Salpetriere, ParisEnglish AbstractGuidelineJournal ArticleResearch Support, Non-U.S. Gov'tReviewFrance. [WWW] Keyword(s): Antiparkinson Agents/*adverse effects/therapeutic use, Heart Valve Diseases/*chemically induced/epidemiology, Humans, Pergolide/*adverse effects/therapeutic use.


  16. S. Lesage, P. Ibanez, E. Lohmann, P. Pollak, F. Tison, M. Tazir, A. L. Leutenegger, J. Guimaraes, A. M. Bonnet, Y. Agid, A. Durr, and A. Brice. G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol, 58(5):784-7, 2005. Note: French Parkinson's Disease Genetics Study GroupComparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Africa, Northern/epidemiology/ethnology, Aged, Aged, 80 and over, DNA Mutational Analysis/methods, *Family Health, Female, France/epidemiology/ethnology, Gene Frequency, Genetic Predisposition to Disease, Genotype, Glycine/*genetics, Humans, Male, Mental Status Schedule/statistics & numerical data, Middle Aged, *Mutation, Parkinson Disease/*genetics, Protein-Serine-Threonine Kinases/*genetics, Serine/*genetics.


  17. M. C. Rodriguez-Oroz, J. A. Obeso, A. E. Lang, J. L. Houeto, P. Pollak, S. Rehncrona, J. Kulisevsky, A. Albanese, J. Volkmann, M. I. Hariz, N. P. Quinn, J. D. Speelman, J. Guridi, I. Zamarbide, A. Gironell, J. Molet, B. Pascual-Sedano, B. Pidoux, A. M. Bonnet, Y. Agid, J. Xie, A. L. Benabid, A. M. Lozano, J. Saint-Cyr, L. Romito, M. F. Contarino, M. Scerrati, V. Fraix, and N. Van Blercom. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain, 128(Pt 10):2240-9, 2005. Note: Clinical TrialJournal ArticleMulticenter StudyEnglanda journal of neurology. [WWW] Keyword(s): Activities of Daily Living, Adult, Aged, Antiparkinson Agents/adverse effects/therapeutic use, Brain/physiopathology, Deep Brain Stimulation/adverse effects/*methods, Dyskinesia, Drug-Induced/physiopathology/therapy, Electrodes, Implanted, Female, Follow-Up Studies, Globus Pallidus/physiopathology, Humans, Levodopa/adverse effects/therapeutic use, Male, Middle Aged, Motor Activity/physiology, Parkinson Disease/drug therapy/physiopathology/*therapy, Subthalamic Nucleus/physiopathology, Time Factors, Treatment Outcome.


  18. W. M. Schupbach, N. Chastan, M. L. Welter, J. L. Houeto, V. Mesnage, A. M. Bonnet, V. Czernecki, D. Maltete, A. Hartmann, L. Mallet, B. Pidoux, D. Dormont, S. Navarro, P. Cornu, A. Mallet, and Y. Agid. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry, 76(12):1640-4, 2005. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Activities of Daily Living, Aged, Antiparkinson Agents/therapeutic use, Cognition Disorders/etiology, *Deep Brain Stimulation, Disease Progression, Female, Follow-Up Studies, Humans, Levodopa/therapeutic use, Male, Middle Aged, Motor Skills Disorders, Parkinson Disease/*therapy, *Subthalamic Nucleus, Treatment Outcome.


  19. P. Ibanez, A. M. Bonnet, B. Debarges, E. Lohmann, F. Tison, P. Pollak, Y. Agid, A. Durr, and A. Brice. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet, 364(9440):1169-71, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Adult, Age of Onset, Aged, Aged, 80 and over, Disease Progression, Female, *Gene Duplication, Humans, Lewy Body Disease/genetics, Male, Microsatellite Repeats, Middle Aged, Mutation, Missense, Nerve Tissue Proteins/*genetics, Parkinson Disease/*genetics, Phenotype, Polymerase Chain Reaction, Synucleins, alpha-Synuclein.


  20. D. Maltete, S. Navarro, M. L. Welter, S. Roche, A. M. Bonnet, J. L. Houeto, V. Mesnage, B. Pidoux, D. Dormont, P. Cornu, and Y. Agid. Subthalamic stimulation in Parkinson disease: with or without anesthesia?. Arch Neurol, 61(3):390-2, 2004. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Aged, Antiparkinson Agents/therapeutic use, Case-Control Studies, Disability Evaluation, Dose-Response Relationship, Radiation, Electric Stimulation Therapy/*methods, Electrodes, Implanted, Female, Follow-Up Studies, Humans, Levodopa/therapeutic use, Male, Middle Aged, Motor Activity/physiology, Parkinson Disease/*therapy, Retrospective Studies, Statistics, Nonparametric, Subthalamic Nucleus/*radiation effects, Time Factors, Treatment Outcome.


  21. V. Mesnage, J. L. Houeto, A. M. Bonnet, I. Clavier, I. Arnulf, F. Cattelin, G. Le Fur, P. Damier, M. L. Welter, and Y. Agid. Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease. Clin Neuropharmacol, 27(3):108-10, 2004. Note: Clinical TrialComparative StudyJournal ArticleRandomized Controlled TrialUnited States. [WWW] Keyword(s): Aged, Antipsychotic Agents/pharmacology/*therapeutic use, Double-Blind Method, Dyskinesia, Drug-Induced/drug therapy/etiology, Female, Humans, Levodopa, Male, Middle Aged, Movement Disorders/drug therapy/etiology, Neurotensin/*antagonists & inhibitors, Parkinson Disease/complications/*drug therapy, Piperidines/pharmacology/therapeutic use, Pyrazoles/pharmacology/therapeutic use, Quinolines/pharmacology/therapeutic use, Receptors, Cannabinoid/*antagonists & inhibitors, Receptors, Neurotensin/*antagonists & inhibitors.


  22. M. L. Welter, J. L. Houeto, A. M. Bonnet, P. B. Bejjani, V. Mesnage, D. Dormont, S. Navarro, P. Cornu, Y. Agid, and B. Pidoux. Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch Neurol, 61(1):89-96, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Aged, *Electric Stimulation Therapy, Electrophysiology, Female, Humans, Male, Middle Aged, Neurons/*physiology, Parkinson Disease/*therapy, Subthalamic Nucleus/physiopathology.


  23. Y. Agid, I. Arnulf, P. Bejjani, F. Bloch, A. M. Bonnet, P. Damier, B. Dubois, C. Francois, J. L. Houeto, D. Iacono, C. Karachi, V. Mesnage, O. Messouak, M. Vidailhet, M. L. Welter, and J. Yelnik. Parkinson's disease is a neuropsychiatric disorder. Adv Neurol, 91:365-70, 2003. Note: Journal ArticleReviewUnited States. [WWW] Keyword(s): Basal Ganglia/pathology/physiopathology, Dopamine/deficiency, Humans, Mental Disorders/*etiology/pathology/*physiopathology, Neural Pathways/metabolism/pathology/physiopathology, Neurons/metabolism/pathology, Parkinson Disease/*complications/physiopathology/*psychology, Substantia Nigra/pathology/physiopathology, Subthalamic Nucleus/pathology/physiopathology.


  24. J. L. Houeto, M. L. Welter, P. B. Bejjani, S. Tezenas du Montcel, A. M. Bonnet, V. Mesnage, S. Navarro, B. Pidoux, D. Dormont, P. Cornu, and Y. Agid. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Arch Neurol, 60(5):690-4, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Disability Evaluation, Dyskinesias/diagnosis/surgery/therapy, *Electric Stimulation Therapy, Female, Humans, Male, Middle Aged, *Monitoring, Intraoperative, Parkinson Disease/diagnosis/*surgery/*therapy, Predictive Value of Tests, Prognosis, Retrospective Studies, Subthalamic Nucleus/*surgery, Treatment Outcome.


  25. B. Jarraya, A. M. Bonnet, C. Duyckaerts, J. L. Houeto, P. Cornu, J. J. Hauw, and Y. Agid. Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study. Mov Disord, 18(12):1517-20, 2003. Note: Case ReportsJournal ArticleUnited Statesofficial journal of the Movement Disorder Society. [WWW] Keyword(s): Aged, Antiparkinson Agents/adverse effects, Cognition Disorders/diagnosis, Disease Progression, Dyskinesia, Drug-Induced/etiology, Electric Stimulation Therapy/*instrumentation, Fatal Outcome, Female, Humans, Levodopa/adverse effects, Neuropsychological Tests, Parkinson Disease/drug therapy/physiopathology/*therapy, Subthalamic Nucleus/*physiology, Tremor/physiopathology.


  26. E. Lohmann, M. Periquet, V. Bonifati, N. W. Wood, G. De Michele, A. M. Bonnet, V. Fraix, E. Broussolle, M. W. Horstink, M. Vidailhet, P. Verpillat, T. Gasser, D. Nicholl, H. Teive, S. Raskin, O. Rascol, A. Destee, M. Ruberg, F. Gasparini, G. Meco, Y. Agid, A. Durr, and A. Brice. How much phenotypic variation can be attributed to parkin genotype?. Ann Neurol, 54(2):176-85, 2003. Note: French Parkinson's Disease Genetics Study GroupEuropean Consortium on Genetic Susceptibility in Parkinson's DiseaseNs41723-01a1/ns/nindsJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.United States. [WWW] Keyword(s): Adolescent, Adult, Age of Onset, Aged, Aged, 80 and over, Antiparkinson Agents/therapeutic use, Disease Progression, Exons/genetics, Female, Genotype, Heterozygote, Humans, Levodopa/therapeutic use, Male, Middle Aged, Mutation/genetics, Mutation, Missense/genetics, Parkinson Disease/drug therapy/*genetics/physiopathology, Phenotype, Ubiquitin-Protein Ligases/*genetics, Variation (Genetics)/*genetics.


  27. C. B. Lucking, V. Chesneau, E. Lohmann, P. Verpillat, C. Dulac, A. M. Bonnet, F. Gasparini, Y. Agid, A. Durr, and A. Brice. Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease. Arch Neurol, 60(9):1253-6, 2003. Note: R01 ns41723-01a1/ns/nindsJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.United States. [WWW] Keyword(s): Adult, Age of Onset, Aged, Aged, 80 and over, Female, Genetic Predisposition to Disease, Genotype, Humans, Ligases/*genetics, Male, Middle Aged, Parkinson Disease/epidemiology/*genetics, Polymorphism, Genetic/*genetics, *Ubiquitin-Protein Ligases.


  28. L. Mallet, V. Mesnage, J. L. Houeto, A. Pelissolo, J. Yelnik, C. Behar, M. Gargiulo, M. L. Welter, A. M. Bonnet, B. Pillon, P. Cornu, D. Dormont, B. Pidoux, J. F. Allilaire, and Y. Agid. Compulsions, Parkinson et stimulation. Rev Neurol (Paris), 159(1):S11-S12, 2003.



BACK TO INDEX



Disclaimer:

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.



Last modified: Thu May 6 18:22:39 2010
Author: schwartz.

This document was translated from BibTEX by bibtex2html